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Summary: The detefrhination of glucose concenträtion is the most frequently used clinical laboratory test. It was the
current vehemence in -discussioris about the judgement eriteria for the diagnosis and monitoring of diabetes that
motivated this discussipn of pathobiöchemical and analytical aspects in a circle of 38 experts. The composition of the
working group made it possible to compare the needs pf clinical diabetologists and diabetics with the analytical possi-
bilties. Pathobiochemistry, sampling problems, diabetic seif eontrol, analytical methods and their standardisation,
glucose monitöring, glucose sensors anä glycosylated pioteiiis were the topics of this glucose workshop.
Ist Glucose ein zuverlässiges Kriterium zur Beurteilung des Kohlenhydratstoffwechsels?
Bericht über die gemeinsame Kleinkonferenz „Gtucose"
der Deutschen Gesellschaf t ßr Klinische Chemie und
d& Deutschen Diabetes-Gesellschaft "
am 15. und 16. Mai 1981
in Stuttgart
Zusammenfassung: Die Bestimmung der Glücosekonzentratipn ist die häufigste Untersuchung im Klinik- und Praxis-
laboratorium. Die derzeit heftig diskutierten Beurteilungskriterien zur Diabetesdiagnostik und -Überwachung gaben
den Anlaß, im Kreise von 38 Experten die pathpbiochemischen und analytischen Teilaspekte zu diskutieren. Die Zu-
sammensetzung des Arbeitskreises ermöglichte eine Gegenüberstellung der Bedürfnisse des klinischen Diabetologen
und des Diabetikers mit den analytischen Möglichkeiten. Pathobiochemie, Probleme der Probenahme, Diabetiker-
Selbstkontrolle, analytische Methoden und deren Standardisierung, Glucosemonitoring, Glucosesensoren und glyco-
sylierte Proteine waren, Schwerpunkte dieser Glucose-Kleinkonferenz.
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Introduction
The determination of glucose concentration is the mpst
frequently used clinical laboratory test. Nevertheless, at
the beginning of this discussion of experts, some partici-
pants doubted that this topic could be treated in a con-
ference of 114 days. This discussion of the pathobio-
chemical and analytic aspects in a circle of experts was
motivated by the current vehemence in discussions about
the judgement criteria for the diagnosis and monitoring
of diabetes. The composition of the working gröup
facilitated a confrontation of the needs of clinical
diabetologists and diabetics with the analytic possi-
bilities. The intimate, convivial framework of the meet-
ing made it possible to reconcile the otherwise often
controversial Standpoints of the clinic and the laboratoiy.
Pathobiochemistry
From the introductory pathobiochemical lectures, it
became clear that the determination of glucose con-
centration in blood (can only be a measure of the size of
the extracellular glucose pool. This pool under eugjycae-
mic conditions consists of 20 g glucose dissolved in 28 l
extracellular glucose space in a 70 kg person (fig. 1). It
is filled exclusively by nutrition and gluconeogenesis,
while many organs contribute to the consumption of
this pool (Dietze, Munich), Under fasting conditions,
the brain, muscle and blood cells are the main organs
involved in glucose uptake (6.8 g/h) while the liver
refills the pool with a production of 7 g/h.
The determination of glucose concentration can neither
disclose the cause of the measured changes in the pool
in a normal subject nor in a diabetic, not even under
loading eonditions. The Interpretation of a change iri
glucose concentration is orily possible with the help of
pathobiochemical knowledge, if we disregard special
techniqües (glucose clarnp teehnique, determination of
the glucose half-life time with radioactive isotopes). The
relätively small reduction of the glucose pööl duriflg
longer periods of fasting is only possible because of the
simultaneous restriction of glucose consumption by
muscle and brain and the increased reflux of Substrates
for hepatic gluconeogenesis. Hypefglycaemiä ean, on the
other hand, be paused by a redüction of peripheräl con=
sumption or by an increase in hepatic production. Both
mechanisms contribute to a disturbed glucose tolerance.
Because of the insulin-dependent glucose transport, the
role of musele and fat tissue is especiälly important for
carbohydrate tolerance. The increase in glucose uptake
in a normal subject due to muscle activity is disturbed
in an insulin-deficient diabetic. Small doses of insuliii
are capable of restoring the increased uptake pf glucose
by working muscles. In contrast to normal subjects, how-
ever, the liver öf an insulin-dependent diabetic cannot
react with a correspöriding increase in glucose produc-
tion, since his glycogenolysis and gluconeogenesis is
inhibited by the therapeutically administered insulin.
This often results in hypoglycaemia. The avoidance of
this is a primary indication for monitoring blood glucose
concentration in insulin-treated diabetics (Kemmer^
Düsseldorf). On the other hand, the kidney plays a sub-
ordinate role in glucose homeostasis since gluconeo-
genesis of the proximal tubule in the kidney is com-
pensated for by the insulin-independent glucose uptake of
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Fig. la. Glucose metabolism after fasting for 15 h overnight.
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glucose production becomes significant only in cases of
lactate acidosis and decompensation of hepatic gluco-
neogenesis. However, äs an excretory organ for glucose,
the kidney can be an essential regulator under hyper-
glycaemic conditions (Henning, Göttingen). Glucose
determination in urine is therefore still important for
monitoring hyperglycaemia. Its Interpretation is, how-
ever, limited because of the lack of precision of routine
methods to determine the renal threshold. The widely
used method of polarimetry was judged to be obsolete
for hospitals (Borner, Berlin) but sufficiently exact and
econoraic for outpatient care (Willms, Bad'Lauterberg;
Kurow, Berlin). In an unselected group of patients,
polarimetry showed false results in 9% of urine samples
and was inferior to the estimation with enzymatic test
Strips .(Appel, Karlsruhe). Above all, with increasing
renal insufficiency, not only the Interpretation of urine
glucose but also of blood glucose becomes difficult. In
spite of these limitations, the determination of glucose
concentration in blood and urine remains the most
important procedure for monitoring carbohydrate
metabolism. This is underlined by the new Undings
which assign a pathogenetic role to hyperglycaemia for
diabetic late complications (O. Wieland, Munich).
Preparing the Patient and Selecting the Time
for Taking the Sample
The influence of foöd on glucose is generally known.
However, besides the deflnition of fasting glucose ( -
5 hours after the last meal), the dietary pretreatment of
the patient is not standardized. 125—150 g of carbo-
hydrate per day, äs recommeiided by WHO for the oral
glucose tolerance test, is not considered to be sufficient
(Otto, Bremen). While the glucose sample is usually
tiaken between 6.00 and 9.00 a.m., opinions differ äs to
the optimal selection of the times for postprandial blood
glucose and 24 h pattern. In general, it is recommended
to täke blood l h after a meal. A general recommenda-
tion caniiot be given for the 24 h curve. It is crucial that
blood sampling is adapted to the individual demands of
the clinicians and the meal times of the patient rather
than the set times layed out by the laboratory (Willms,
Bad Lauterberg). Although a dependence of the behav-
iour of glucose on the time of day is observed by clini-
cians, a rigid, endogenous diurnal rhythm of glucose can-
not be demonstrated (Wisser, Stuttgart). The time differ-
ences in the behaviour of blood glucose during the oral
glucose tolerance test or insulin therapy are apparently
dependent upon exogenous, nutrition-dependent regu-
latory mechanisms (e.g. fatty acids, catecholamines).
Sampling
The capillary blood sample is seen äs the optimal speci-
men for judging metabolic Status. Although there is no
significant difference between venous and capillary
glucose concentration in fasting persons, the difference
can reach a maximum of 30-60 mg/dl (l .7-3.4 mmol/1)
depending upon the amount of orally administered
glucose (Haslbeck, Munich', Förster, Frankfurt). Under
nonfasting conditions, the capillary-venous differences
are highest after breakfast and can then reach a maxi-
mum of 20 mg/dl. They also depend on the time inter-
val after glucose administration, the degree of overweight
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Fig. Ib. Glucose metabolism in acute insulin deficiency.
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calculation of capillary blood glueose values from venous
results can therefore not be recommended. Similarly,
blood values should not be calculated from serum or
plasma results. The plasma value is generally higher than
that for blood (3-10 mg/dl for fasting blood (Schmidt,
Mannheim)), but in individual cases calculation is not
possible (Thomas, Wiesbaden). Last, but not least, since
the arteriovenous or the capillary-venous difference
depends on the method of analysis (Weiss, Munich), one
should uniformly use capillary blood for blood sugar
determination. For this purpose., small volume capillaries
(10-50 ) are preferable to larger ones. Thin, long
capillaries allow more exact blood sampling than short,
thick ones (Weiss, Munich). With fluoride or maleinimide,
the glueose concentration in capillary blood can be
sufficiently stabilized so that mailing of capillary blood
samples is possible without deproteinization (Schmidt,
Mannheim). The filter papers introduced for phenyU
ketonuria screening may, after impregnation with boric
acid, also be used for mailing capillary whole blood
samples (Kruse-Jarres, Stuttgart). An exact quantifica-
tion of capillary blood can be achieved in the laboratory
if more than 50 of stabilized blood is drawn. Because
of the danger of glycolysis, samples without additive äs
well äs venous blood samples should not be used for
analysis at all. Even if these factors are corisidered, the
sampling error is twice äs high äs the analytical errors
(Stamm, Munich).
Dernands Made by the Clinical Diabetologists and the
Diabetic on the Laboratory
The demands of the clinician presented by Otto (Bre-
men) correspond largely with those of the diabetologist
in practice (Kurow, Berlin): a nonirivasive method
would be optimal; considering the current possibilities,
the sampling procedure should be äs painless äs possible
and allow quick, quantitative determination without
prior calibration of the blood sample. Simple apparatus
which allows a determination with a maximal Variation
of ± 15% would be sufficient for seif control of diabe-
tics. Independence from measuring devices would also
be desirable for that purpose.
Diabetic Seif Control
Monitoring of carbohydrate metabolism by the diabetic
patient himself is, with the corresponding training and
intelligence, better than sporadic control of blood glueose
by the doctor. Blood sugar seif control should be re-
stricted to special indications such äs hyppglycaemia
without warning Symptoms, changes in renal threshold
in pätients with renal insufficieney, or during pregnancy.
Otherwise it can provide very little Information in addi-
tion to urine glueose seif control (Willms, Bad Lauter-
berg). There are considerable differences in the evalua-
tion of the methods for seif control. Selected and trained
pätients can measure blood glueose very accurately with
test strip reflectorneters (Busch, Mannheim), but if the
reflectometers are not properly contrölled, considerable
differences can arise. Some diabetics educated in natural
sciences may use quantitative photometry for glucose
determination in their own laboratory, but this is cer-
tainly an exception (Thomas, Wiesbaden). · r
Analytical Methods and Their Standardization
In contrast to the United States, in Germany the chemi-
cal methods for blood glueose determination have beeri
largely replaced by enzymatic procedures. However,
there is still a wide ränge of methodological variants,
which result not only from the choice of material under
investigation (plasma, blood, haerriölysatej deproteinized
supernatant), but also from the secondaiy f eagents used
in the glueose oxidase method, the temperature and
kifid of measurement (kinetic, ßxed time, end point),
and the form of the erizyme (wet, matrix-böund, dry)
(Guder, Munich). The interläboratory sufveys of the
Bayerische Kassenärztliche Vereinigung, which represent
ä large field study with 5000 participants, gave a blood
glueose deviation of üp to ± 20 mg/dl at an assigned välüe
of 100 mg/dl, not considering the methodölogy; This
Variation is caüsed chiefly by matrix effects, thus making
a comparison of the methods qüestionable (Stamm,
Munich). Smaller differences between the hexokinase
method and the glueose dehydrogenase method have
been eliminated in the meantime by ehanging the
reagents (Lang, Darmstädt). Nevertheless, there äre still
considerable differences between the different glueose
oxidase methods, especially if the samples contain uric
acid or other interfering substances (Stamm, Müriich).
The most freqüently used deproteinizing agent in the
hexokinase and glueose dehydrogenase method is per-
cMoric acid, while uranyl acetate and the Somogyi-Nel-
son deproteinization with zinc sülfate/barium hydroxide
is suited for the glueose oxidase method. Stabilized
haemolysate and whole blood are, however, being in-
creasingly used äs samples. With haemolysate, the
disturbance caüsed by erythrocyte enzymes due to
fructose müst be considered; the use of whole blood in
Instruments with an öxygen electrodfc fequires the
Standardization of the oxygenation of the sample (Ren-
ner, Munich). A coefficient of Variation of 2-3%
should be obtained in an optimal procedure in order
to reach the preeisiön of 5%'desired by clinicians arid
diabetics (Haeckel, Hannover). The day to day Variation
of 5% is not adequate for optimal diabetes diagnosis.
In addition, there äre several interferirig factors that the
clinical chemists should try to eliminate: Thus uranyl
acetate can only be used äs a deproteinizing agent when
the sample contains enpugh protein. Otherwise, the
surplus uranyl ions must be pfecipitated from the super-
natant with a phosphate buffer (Weiss, Munich), Bili-
rubin interferes with double wavelength methods which
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measure at 340 and 380 nm (Haeckel, Hannover). A
large number of drugs and metabolites (e.g. acetyl-
salicylic acid, DOPA, uric acid) can interfere with un-
specific methods (also glucose oxidase methods) in
vitro and in vivo; these therefore interfere in urine
analysis (Borner, Berlin). Everi glucose determination
with dry reagents which fulfills the demands of a
precise method, are susceptible to disturbances due to
matrix effects (Wisser, Stuttgart). In general, the latter
methods show a good correlation with the hexokinase/
glucoseö-phosphate dehydrogenase method (Thomas,
Wiesbaden).
In view of the large number of methodolögical variants,
standardization seems advisable. There is, however, no
internationally accepted reference method to date.
Isotope dilution, gas chromatography, mass spectro-
metry (Björkhem et al. and National Bureau of Standards,
U.S.A.) and hexokinase/glucose-6-phosphate dehydro-
genase (United States' Department of Health Education
and Weifare) are relatively well tried methods. They
show an analytical coefficient of Variation of 2% at
the most (Dybkaer, Copenhagen). In practice, the
means of the assigned values for the hexokinase and
glucose dehydrogenase method of the German inter-
laboratory surveys meet this Standard (Stamm, Munich).
The description of the manual methods for glucose
determination äs a DIN-norm has been proposed for
hexokinase arid glucose oxidase (Stähler, Tutzing).
Efforts are being made to give the assigned values and
the ränge of scattering for the internal and external
quality control for the reference method only. Then the
variety of modificatiöns can be adjusted accördingly.
With this procedure, standardization and simplification
of the quality eontrol procedure are achieved at the
same time.
Glucose Monitoring
The continupus recording of blood glucose is not so
much an alternative to the usual random control (24 h
pattern) but rather a valuable Supplement to the solution
of particular prpblems in diabetölogy. This kind of
analysis can solve therapeutic problems together with
a coupled insulin Infusion System (e.g. paradoxical insu-
lin effectiveriess, questionable routes of administration)
(Kritz, Vienna). One can usually do withöut the con-
tinuous glucose recording in the pperi-lpop Systems.
Such analytical devices may be of use for scientific
prpblems conceriiing the Imitation of physiological
patterns of insulin secretion and the question of infusion
therapy with more than one hormone, äs well äs the
socalled "motion induced gjycaemic excursions" (Ren-
ner, Munich). Even though some centres appear success-
ful in achieving an improvement in the normalization
of blpod glucose by using a real feedback System (Ker-
ner, U\m',Jipp, Stuttgart), we have still not reached the
stage where those not having this equipment available
must reproach themselves for offering inferior diabetes
treatment (Otto, Bremen). As yet, there exist no defmed
indications for the diabetologist äs to the therapeutic
application of such insulin-infusion Systems which are
self-operating in response to the actual blood glucose
concentration.
Glucose Sensors
A significant breakthrough to the solution of glucose
measurements either invasively or noninvasively cannot
be reported (Schaldach, Erlangen). All invasive Systems
so far have only lirnited application since they have con-
siderable disadvantages (e.g. energy supply, sensitivity to
interfering factors etc.). The best known procedure is a
fuel cell which oxidizes glucose itself. The disadvantage
is that a number of other components in the blood
falsify the energetic interaction between the electrodes
and the medium to be analyzed, especially during
metabolic decompensation. With respect to the non-
invasive methods, IR spectrometry with attenuated
total reflection (ATR) plates optimized by a C02 laser
is the only currently feasible procedure which is how-
ever, far from being successfully put into practice
(Kruse-Jarres, Stuttgart). An alternative which seems
ingenious in theory and would make therapy possible
at the same time, would be the use of glycosylated
insulin which has sufficient biological activity. This
could be implanted äs a biologically inactive complex
with lectin and then set free from lectin again by glucose
(Wieland, Munich). Determinations of insulin, pro-
insulin, and C peptide are not necessary for routine
diabetology and do not therefore represent alternatives
or regulär complements to glucose determinations.
Besjdes research, their domain is the differentiatiori of
conditipns for which glucose is an unreliable parameter
(e.g. hypoglycaeniia). in addition there are consider-
able methodolögical difficulties, which, for example,
lead to pporly comparable normal rariges due to the
heterogeneity pf Standard materials and the antisera
used (Gerbitz, Munich).
Glycosylated Proteins
Our iriformation on enzymatic and nonenzymatic
glycosylation of proteins in relation to blood glucose
levels is still incomplete. However, beyond the known
data, there are hopeful beginnings in both areas, which
are of possible diagnostic value.
HbA! is widely seen äs the main representative of non-
enzymatically glycosylated proteins. There are currently
at least 6 different methods of determination available.
Some techniques include only N-terminal glycosylated
haemoglobin; others apparently also include other
amino acids (lysine) of glycosylated haemoglobin. On
the basis of bis comparative study,Reinauer (Düsserdorf)
suggests using the HPLC method äs a reference method.
J, din. Chem. Clin/Biochem. / Vol. 20,1982 / No. 3
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For routine analysis however, the thiobarbituric acid
method and the macrocolumn procedure are recom-
mended. An external quality eontrol for improving the
comparability of results is proposed and urgently in-
dicated. According to Dolhofer (Munich), the reliable
determination of the stable ketoaniine form of HbAj
will only succeed with sufficiently long columns and
slow elution. Under the conditions of commercial micro-
columns, not only the stable forms are collected, but
also the labile forms, even after dialysis. Whether the
simultaneous determination of the labile forms (Schiff
base) and the stable form (ketoamine) offers valuable
additional Information in diabetologic practice will
have to be proven by further experience. According to
Henrichs (Quakenbrück), a significant increase of the
unstable form of HbAj is observed if the mean blood
glucose remains above 160 mg/dl for 12 h. In principle,
simultaneous determination of several glycosylated
proteins with differing association and turnover kinetics
should open the possibility of gaining closer insight into
the glycaemia history of the patient.
The determination of lysine bound glucose (fürosine) in
albumin of human serum seems to be of great interest.
The method used for glycosylated albumin is more
specific than others for determining glycosylated
proteins because only the ketoamine form is measured
(Schleicher, Munich).
The lipoproteins (HOL, VLDL and LDL) in plasma also
contain 2—3% carbohydrates. This is due to enzymatic
glycosylation involving mainly neutral sugars (glucose,
galactose and mannose), amino sugärs (N-acetyl-glucos-
aminej N-acetyl-galactosamine) and N-acetylneuraminic
acid. The determination of these carbohydrate com-
ponents in lipoprdteins may becqme diagnostically
interesting äs the carbohydf ate content of VLDL is
found to be in good correlation to blood glucose and to
HbAi in insulin dependent diäbetics ( ,
Mannheim). When analyzed chromatographiGally, gälac^
tose and nianftose äs well äs the hexosamines GlcNAc
and GalNAc are found to be iricreased in diabetes.
During therapy, the hexosarnine concenträtion drops
froiii a maximum of about 300 nmol/mg apolipoprötein
to normal valües within ä few days. This irieäns that
the changes, like those in glycosylated albumin, are
more rapidly reversible thän those in HbAj . In addition,
it seems interesting that an increased nonenzymatic
glycosylation of lipppröteins is also found in diäbetics
i Munich).
The lattef findings extend our knowledge far beyond the
Information of blpöd glucose eoncentrations. The in-
creased glycosylation of VLDL apolipoprötein could,
for example, be responsible for the delayed triglycende
clearance and thus for the hypertriglyceridäemia in
diabetes. Changes in gjycosylation of LDL or HOL could
lead to an alteration in binding to the specific lipo-
pfotein receptors at the cell sürface. By such a meehanism
these findings would deserve much interest with respect
to the pathogenesis of the diabetic vascular complica-
tions.
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